SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jeffbas who wrote (6833)4/19/1999 10:15:00 AM
From: TwoBear  Read Replies (1) of 78571
 
There are similarities, but, different cancers arise from different celluar structures. What might turn on a mutation in a epithelial cell will not be the same catalyst for a glandualar cell. Each of these cells react differently to different types of treatment. Cancers such as kidney, liver, and melanoma respond poorly to radiation, whereas, lymphoma, Hodgkin's disease, and basal cell skin cancers respond greatly.

I guess what I'm trying to say is there will be no magic bullet such as penicillin with cancer. As I'm sure you know, we are now running out of antibiotics to treat many infectious diseases due to their ability to adapt and evolve to such drugs as penicillin.

Tubes crack due to high heat generated in the tube. When x-rays are produced they are only 2% of the product. The other 98% is heat. Often a machine's use is limited while waiting on cooling of the tube. Sometimes technologists don't wait and overheat the tube thereby damaging it. I will investigate this issue further.

2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext